![Michelle Morrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Morrow
No más puestos en curso
Perfil
Michelle Morrow worked as Chief Scientific Officer at Avacta Group Plc from 2024 to 2026.
Dr. Morrow also worked as Senior VP & Head-Therapeutics Innovation at invoX Pharma Ltd. Dr. Morrow earned a doctorate from the University of Cambridge.
Antiguos cargos conocidos de Michelle Morrow.
| Empresas | Cargo | Fin |
|---|---|---|
| AVACTA GROUP PLC | Director Técnico/Científico/I+D | 09/02/2026 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | - |
Formación de Michelle Morrow.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
- Bolsa de valores
- Insiders
- Michelle Morrow
